AstraZeneca (AZN) Stock Forecast & Price Target
Score
AstraZeneca PLC price target
| AZN | |
|---|---|
| Low | $206.00 |
| Average | $211.00 |
| High | $216.00 |
| Upside vs current price | +18.2% |
The average target of $211.00 is +18.2% versus the current AZN price of $178.57.
AstraZeneca PLC analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 2 |
| Buy | 7 |
| Hold | 2 |
| Sell | 1 |
| Strong sell | 0 |
| Consensus | Buy |
12 analysts cover AZN.
AstraZeneca PLC EPS and revenue estimates
Published annual figures for AZN on this page are 2026 EPS $10.26, 2027 EPS $11.35. Coverage under three analysts is omitted.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $10.26 | $62.71B |
| 2027 | $11.35 | $66.79B |
Is AstraZeneca PLC a buy or sell?
Of the 12 analysts covering AstraZeneca PLC, 9 rate it a buy (2 strong buy and 7 buy), 2 rate it a hold, and 1 rates it a sell (1 sell and 0 strong sell).
The AZN consensus label is Buy, beside 9 buy-side ratings and 1 sell-side ratings.
The average target of $211.00 implies +18.2% versus the current price of $178.57.
The AZN rating block is 12 published views with a Buy label. It does not tell you whether to buy or sell.
Reading the AstraZeneca PLC forecast
the AstraZeneca PLC has a tight target cluster: $206.00 to $216.00, average $211.00.
The gap from the $178.57 price to the AZN average is +18.2%.
The AZN rating mix is lopsided rather than split: 9 of 12 analysts are on the buy side, 2 are at hold, and 1 is on the sell side, and the published consensus is Buy.
the AstraZeneca PLC has a rising EPS path, $10.26 for 2026 and $11.35 for 2027.
With 12 analysts on AZN, the average is a small sample.
AstraZeneca PLC forecast questions
What is the AZN price target?
The published range for AZN is $206.00 to $216.00, with an average of $211.00. That average is +18.2% versus the current price of $178.57.
Is AstraZeneca PLC a buy or sell?
Of the 12 analysts covering AstraZeneca PLC, 9 rate it a buy, 2 rate it a hold, and 1 rates it a sell. The consensus is Buy, leaving AZN at 9 buy ratings, 2 holds, and 1 sells.
What is the EPS estimate for AstraZeneca PLC?
Analyst EPS estimates for AstraZeneca PLC: 2026 $10.26, 2027 $11.35.
What is the revenue estimate for AstraZeneca PLC?
Analyst revenue estimates for AstraZeneca PLC: 2026 $62.71B, 2027 $66.79B.
How many analysts cover AZN?
12 analysts cover AZN. Their consensus on AZN is Buy, across those 12.